139 related articles for article (PubMed ID: 36648309)
1. Targeted sequencing of a gene panel in patients with familial hypercholesterolemia from Southern Poland.
Totoń-Żurańska J; Wołkow P; Kapusta M; Wójcik M; Starzyk J; Kawalec E; Idzior-Waluś B; Waluś-Miarka M
Pol Arch Intern Med; 2023 Jun; 133(6):. PubMed ID: 36648309
[TBL] [Abstract][Full Text] [Related]
2. Identification of New Genetic Determinants in Pediatric Patients with Familial Hypercholesterolemia Using a Custom NGS Panel.
Rutkowska L; Sałacińska K; Salachna D; Matusik P; Pinkier I; Kępczyński Ł; Piotrowicz M; Starostecka E; Lewiński A; Gach A
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741760
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of familial hypercholesterolemia in Asian Indians: A single-center study.
Setia N; Movva S; Balakrishnan P; Biji IK; Sawhney JPS; Puri R; Arora A; Puri RD; Saxena R; Mishra S; Apte S; Kulshrestha S; Ramprasad VL; Verma IC
J Clin Lipidol; 2020; 14(1):35-45. PubMed ID: 32044282
[TBL] [Abstract][Full Text] [Related]
4. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
[TBL] [Abstract][Full Text] [Related]
5. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
[TBL] [Abstract][Full Text] [Related]
6. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
[TBL] [Abstract][Full Text] [Related]
8. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
[TBL] [Abstract][Full Text] [Related]
9. Cascade screening and genetic diagnosis of familial hypercholesterolemia in clusters of the Southeastern region from Brazil.
de Paiva Silvino JP; Jannes CE; Tada MT; Lima IR; Silva IFO; Pereira AC; Gomes KB
Mol Biol Rep; 2020 Dec; 47(12):9279-9288. PubMed ID: 33231818
[TBL] [Abstract][Full Text] [Related]
10. Genetic Spectrum of Familial Hypercholesterolaemia in the Malaysian Community: Identification of Pathogenic Gene Variants Using Targeted Next-Generation Sequencing.
Razman AZ; Chua YA; Mohd Kasim NA; Al-Khateeb A; Sheikh Abdul Kadir SH; Jusoh SA; Nawawi H;
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499307
[TBL] [Abstract][Full Text] [Related]
11. Genetic Analysis of Japanese Children Clinically Diagnosed with Familial Hypercholesterolemia.
Nagahara K; Nishibukuro T; Ogiwara Y; Ikegawa K; Tada H; Yamagishi M; Kawashiri MA; Ochi A; Toyoda J; Nakano Y; Adachi M; Mizuno K; Hasegawa Y; Dobashi K
J Atheroscler Thromb; 2022 May; 29(5):667-677. PubMed ID: 34011801
[TBL] [Abstract][Full Text] [Related]
12. Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia.
Wang H; Yang H; Liu Z; Cui K; Zhang Y; Zhang Y; Zhao K; Yin K; Li W; Zhou Z
J Atheroscler Thromb; 2020 Dec; 27(12):1288-1298. PubMed ID: 32759540
[TBL] [Abstract][Full Text] [Related]
13. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
[TBL] [Abstract][Full Text] [Related]
14. Whole-Gene Duplication of PCSK9 as a Novel Genetic Mechanism for Severe Familial Hypercholesterolemia.
Iacocca MA; Wang J; Sarkar S; Dron JS; Lagace T; McIntyre AD; Lau P; Robinson JF; Yang P; Knoll JH; Cao H; McPherson R; Hegele RA
Can J Cardiol; 2018 Oct; 34(10):1316-1324. PubMed ID: 30269829
[TBL] [Abstract][Full Text] [Related]
15. Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype.
Medeiros AM; Alves AC; Miranda B; Chora JR; Bourbon M;
J Lipid Res; 2024 Feb; 65(2):100490. PubMed ID: 38122934
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
[TBL] [Abstract][Full Text] [Related]
17. Genetic Analysis in a Taiwanese Cohort of 750 Index Patients with Clinically Diagnosed Familial Hypercholesterolemia.
Huang CC; Niu DM; Charng MJ
J Atheroscler Thromb; 2022 May; 29(5):639-653. PubMed ID: 33994402
[TBL] [Abstract][Full Text] [Related]
18. ABCG5 and ABCG8 genetic variants in familial hypercholesterolemia.
Reeskamp LF; Volta A; Zuurbier L; Defesche JC; Hovingh GK; Grefhorst A
J Clin Lipidol; 2020; 14(2):207-217.e7. PubMed ID: 32088153
[TBL] [Abstract][Full Text] [Related]
19. Identification of pathogenic variants in the Brazilian cohort with Familial hypercholesterolemia using exon-targeted gene sequencing.
Borges JB; Oliveira VF; Dagli-Hernandez C; Ferreira GM; Barbosa TKAA; da Silva Rodrigues Marçal E; Los B; Malaquias VB; Bortolin RH; Freitas RCC; Mori AA; Bastos GM; Gonçalves RM; Araújo DB; Zatz H; Bertolami A; Faludi AA; Bertolami MC; de Moraes Rego Souza AG; França JÍD; Thurow HS; Hirata TDC; Nakaya HTI; Jannes CE; da Costa Pereira A; Silbiger VN; Luchessi AD; Araújo JNG; Nakazone MA; Carmo TS; Souza DRS; Moriel P; Wang JYT; Naslavsky MS; Gorjão R; Pithon-Curi TC; Curi R; Fajardo CM; Wang HL; Garófalo AR; Cerda A; Sampaio MF; Hirata RDC; Hirata MH
Gene; 2023 Jul; 875():147501. PubMed ID: 37217153
[TBL] [Abstract][Full Text] [Related]
20. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach.
de Freitas RCC; Bortolin RH; Borges JB; de Oliveira VF; Dagli-Hernandez C; Marçal EDSR; Bastos GM; Gonçalves RM; Faludi AA; Silbiger VN; Luchessi AD; Hirata RDC; Hirata MH
Mol Biol Rep; 2023 Nov; 50(11):9165-9177. PubMed ID: 37776414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]